相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chiglitazar: First Approval
Emma D. Deeks
DRUGS (2022)
NLRP3 inflammasome as a key driver of vascular disease
Masafumi Takahashi
CARDIOVASCULAR RESEARCH (2022)
Atherosclerosis: Recent developments
Johan L. M. Bjoerkegren et al.
CELL (2022)
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
Anthos Christofides et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6
Daniel J. Tyrrell et al.
NATURE REVIEWS CARDIOLOGY (2021)
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Sven M. Francque et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases
Jun Ren et al.
NATURE REVIEWS CARDIOLOGY (2021)
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
Paul M. Ridker et al.
CIRCULATION RESEARCH (2021)
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Paul M. Ridker et al.
LANCET (2021)
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
Trevor P. Fidler et al.
NATURE (2021)
Platelet activating-factor acetylhydrolase II: A member of phospholipase A2 family that hydrolyzes oxidized phospholipids
Linyue Dong et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2021)
Role of myeloid-derived chemokine CCL5/RANTES at an early stage of atherosclerosis
Jenny Jongstra-Bilen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)
MKP-1 Overexpression Reduces Postischemic Myocardial Damage through Attenuation of ER Stress and Mitochondrial Damage
Xiaoling Hou et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis
Huxinyue Duan et al.
PHARMACOLOGICAL RESEARCH (2021)
Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation
Gissette Reyes-Soffer et al.
PHARMACOLOGICAL RESEARCH (2021)
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Antonio Abbate et al.
CIRCULATION RESEARCH (2020)
Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
Johan G. Schnitzler et al.
CIRCULATION RESEARCH (2020)
IgM natural antibody T15/E06 in atherosclerosis
Jin Zou et al.
CLINICA CHIMICA ACTA (2020)
Vascular Lipidomic Profiling of Potential Endogenous Fatty Acid PPAR Ligands Reveals the Coronary Artery as Major Producer of CYP450-Derived Epoxy Fatty Acids
Matthew L. Edin et al.
CELLS (2020)
T cell subsets and functions in atherosclerosis
Ryosuke Saigusa et al.
NATURE REVIEWS CARDIOLOGY (2020)
Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis
Gabriel F. Alencar et al.
CIRCULATION (2020)
CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications
Kunming Tian et al.
CURRENT ATHEROSCLEROSIS REPORTS (2020)
An update on lipid oxidation and inflammation in cardiovascular diseases
Shanshan Zhong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis
Linzhang Huang et al.
NATURE (2019)
Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis
MacRae F. Linton et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease
Sebastian Steven et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence
Hong Sheng Cheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Immunity and Inflammation in Atherosclerosis
Dennis Wolf et al.
CIRCULATION RESEARCH (2019)
Geniposide regulates the miR-101/MKP-1/p38 pathway and alleviates atherosclerosis inflammatory injury in ApoE-/- mice
Saibo Cheng et al.
IMMUNOBIOLOGY (2019)
Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis
Qi Chen et al.
THERANOSTICS (2019)
Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation
Fumiaki Ito et al.
ANTIOXIDANTS (2019)
Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis
Mandy O. J. Grootaert et al.
CARDIOVASCULAR RESEARCH (2018)
Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases
Zhaoqi Yan et al.
CLINICAL IMMUNOLOGY (2018)
Regulation of macrophage immunometabolism in atherosclerosis
Graeme J. Koelwyn et al.
NATURE IMMUNOLOGY (2018)
Inflammatory and atherogenic effects of oxidized phospholipids
Gregory B. Lim
NATURE REVIEWS CARDIOLOGY (2018)
Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism
Vlad Serbulea et al.
MOLECULAR METABOLISM (2018)
Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
Xuchu Que et al.
NATURE (2018)
Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria
Mengqing Xiao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Monocyte-Macrophages and T Cells in Atherosclerosis
Ira Tabas et al.
IMMUNITY (2017)
Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety in vitro and in vivo: Implication in atherosclerosis
Jianhong Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The oxidized phospholipid POVPC impairs endothelial function and vasodilation via uncoupling endothelial nitric oxide synthase
Feng-Xia Yan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
The apolipoprotein A-I mimetic peptide, D-4F, alleviates ox-LDL-induced oxidative stress and promotes endothelial repair through the eNOS/HO-1 pathway
Donghui Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological Basis of CANTOS and Beyond
Peter Libby
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation
Beatrice Oehler et al.
SCIENTIFIC REPORTS (2017)
Arterial structure and function in vascular ageing: are you as old as your arteries?
Dick H. J. Thijssen et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans
Fleur M. van der Valk et al.
CIRCULATION (2016)
Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin
Paul M. Ridker
EUROPEAN HEART JOURNAL (2016)
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
Borge G. Nordestgaard et al.
JOURNAL OF LIPID RESEARCH (2016)
An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells
Ivan Zanoni et al.
SCIENCE (2016)
Phospholipid oxidation generates potent anti-inflammatory lipid mediators that mimic structurally related pro-resolving eicosanoids by activating Nrf2
Peter Bretscher et al.
EMBO MOLECULAR MEDICINE (2015)
Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)
Corey A. Scipione et al.
JOURNAL OF LIPID RESEARCH (2015)
Macrophage subsets in atherosclerosis
Giulia Chinetti-Gbaguidi et al.
NATURE REVIEWS CARDIOLOGY (2015)
Eicosanoid storm in infection and inflammation
Edward A. Dennis et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Mitogen-Activated Protein Kinase Phosphatase 1 as an Inflammatory Factor and Drug Target
Riku Korhonen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
CD36, a scavenger receptor implicated in atherosclerosis
Young Mi Park
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1
Riku Korhonen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Inhibition of Oxidized-Phospholipid-Induced Vascular Smooth Muscle Cell Proliferation by Resveratrol Is Associated with Reducing Cx43 Phosphorylation
Yue Shi et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma
Philipp Wiesner et al.
JOURNAL OF LIPID RESEARCH (2013)
Role of mitochondria in programmed cell death mediated by arachidonic acid-derived eicosanoids
Huiyong Yin et al.
MITOCHONDRION (2013)
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
Takuma Misawa et al.
NATURE IMMUNOLOGY (2013)
Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining Inflammatory Macrophage Activation
Maria Salagianni et al.
CIRCULATION (2012)
Role of Phospholipid Oxidation Products in Atherosclerosis
Sangderk Lee et al.
CIRCULATION RESEARCH (2012)
Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists
Linda K. Curtiss et al.
JOURNAL OF LIPID RESEARCH (2012)
Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment
Hong Seok Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Tissue factor pathway inhibitor 2 is induced by thrombin in human macrophages
Jordi Pou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Recombinant TFPI-2 enhances macrophage apoptosis through upregulation of Fas/FasL
Jun-jie Pan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
The effect of interleukin-10 on apoptosis in macrophages stimulated by oxLDL
Hong Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice
Geoffrey D. Wool et al.
FASEB JOURNAL (2011)
Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2
Alexandra Kadl et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Vav Protein Guanine Nucleotide Exchange Factor Regulates CD36 Protein-mediated Macrophage Foam Cell Formation via Calcium and Dynamin-dependent Processes
S. Ohidar Rahaman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression
Sotirios Tsimikas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2): a review
Isis T. Silva et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Generation and Biological Activities of Oxidized Phospholipids
Valery N. Bochkov et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Extracellular phospholipases in atherosclerosis
Sonia-Athina Karabina et al.
BIOCHIMIE (2010)
Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress
Tracie A. Seimon et al.
CELL METABOLISM (2010)
Identification of a Novel Macrophage Phenotype That Develops in Response to Atherogenic Phospholipids via Nrf2
Alexandra Kadl et al.
CIRCULATION RESEARCH (2010)
Interdependent biological systems, multi-functional molecules: The evolving role of tissue factor pathway inhibitor beyond anti-coagulation
Eric W. Holroyd et al.
THROMBOSIS RESEARCH (2010)
Oxidized Phospholipid Species Promote in Vivo Differential Cx43 Phosphorylation and Vascular Smooth Muscle Cell Proliferation
Scott R. Johnstone et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Epigenetic regulation of dendritic cell differentiation and function by oxidized phospholipids
Stephan Blueml et al.
BLOOD (2009)
Oxidized Phospholipids Induce Type VIII Collagen Expression and Vascular Smooth Muscle Cell Migration
Olga A. Cherepanova et al.
CIRCULATION RESEARCH (2009)
Oxidized phospholipids in control of inflammation and endothelial barrier
Panfeng Fu et al.
TRANSLATIONAL RESEARCH (2009)
Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis
Mustafa Zakkar et al.
CIRCULATION RESEARCH (2008)
Oxidized phospholipids induce anergy in human peripheral blood T cells
Maria Seyerl et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Endothelial cell regulation by phospholipid oxidation products
Judith A. Berliner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro
Nataliya A. Pidkovka et al.
CIRCULATION RESEARCH (2007)
PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties
M. Amine Bouhlel et al.
CELL METABOLISM (2007)
Oxidized phospholipids: From molecular properties to disease
Gilbert O. Fruhwirth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory
Nima M. Gharavi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids
Alejandro Zimman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters
Tadashi Yoshida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis
Lacramioara Ivanciu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells
Keiko Kawai-Kowase et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells
Michael E. Greenberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Oxidized phospholipid:: POVPC binds to platelet-activating-factor receptor on human macrophages implications in atherosclerosis
Sophie Pegorier et al.
ATHEROSCLEROSIS (2006)
A CD36-dependent signaling cascade is necessary for macrophage foam cell formation
S. Ohidar Rahaman et al.
CELL METABOLISM (2006)
The oxidized phospholipids POVPC and PGPC inhibit growth and induce apoptosis in vascular smooth muscle cells
Gilbert O. Fruhwirth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids
Peter S. Gargalovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids
NM Gharavi et al.
CIRCULATION RESEARCH (2006)
Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC
RS Li et al.
CIRCULATION RESEARCH (2006)
Secretory phospholipases A2 in inflammatory and allergic diseases:: Not just enzymes
M Triggiani et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Oxidized phospholipids trigger atherogenic inflammation in murine arteries
A Furnkranz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
CD36 is a sensor of diacylglycerides
K Hoebe et al.
NATURE (2005)
Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region
N Ohkura et al.
ANTIOXIDANTS & REDOX SIGNALING (2004)
Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory
MK Chang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway
M Yeh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase - Implication for atherosclerosis
M Eisaf et al.
BIOCHEMICAL PHARMACOLOGY (2003)
New markers of inflammation and endothelial cell activation - Part I
PE Szmitko et al.
CIRCULATION (2003)
Lipoprotein (a) downregulates lysosomal acid lipase and induces interleukin-6 in human blood monocytes
C Buechler et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells
A Loidl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway
AL Cole et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2
KA Walton et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis
S Heeneman et al.
JOURNAL OF PATHOLOGY (2003)
Platelets in atherothrombosis
ZM Ruggeri
NATURE MEDICINE (2002)
Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36
EA Podrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of vascular cells by PAF-like lipids in oxidized LDL
GK Marathe et al.
VASCULAR PHARMACOLOGY (2002)
Tissue factor and coronary artery disease
AHM Moons et al.
CARDIOVASCULAR RESEARCH (2002)
Phospholipase A(2)
M Murakami et al.
JOURNAL OF BIOCHEMISTRY (2002)
Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions
J Huber et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Mitogen-activated protein kinase phosphatase 1 activity is necessary for oxidized phospholipids to induce monocyte chemotactic activity in human aortic endothelial cells
S Reddy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor γ ligands and agonists
SS Davies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Tissue factor pathway inhibitor inhibits endothelial cell proliferation via association with the very low density lipoprotein receptor
TA Hembrough et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma
KH Han et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
